Mimedx (MDXG) Cash from Investing Activities (2011 - 2026)

Mimedx has disclosed Cash from Investing Activities across 16 years of filings, most recently posting -$5.6 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$5.6 million, down 1289.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.1 million (down 205.73% YoY), and the FY2025 annual result was -$6.9 million, up 28.14% from the prior year.
• Cash from Investing Activities came in at -$5.6 million for Q1 2026 at Mimedx, down from -$335000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $113000.0 in Q3 2024 to a low of -$6.0 million in Q1 2024.
• The 5-year median for Cash from Investing Activities is -$649000.0 (2023), against an average of -$1.6 million.
• Across the five-year window, Cash from Investing Activities jumped 117.41% in 2024 and tumbled 4753.1% in 2025, its largest moves.
• Mimedx's Cash from Investing Activities stood at -$1.7 million in 2022, then soared by 71.85% to -$481000.0 in 2023, then slumped by 475.26% to -$2.8 million in 2024, then soared by 87.89% to -$335000.0 in 2025, then tumbled by 1584.18% to -$5.6 million in 2026.
• The last three Cash from Investing Activities figures came in at -$5.6 million (Q1 2026), -$335000.0 (Q4 2025), and -$5.3 million (Q3 2025), per Business Quant data.